Leeds-based medtech firm Eventum Orthopaedics has raised £3.8 million to scale its QuadSense device, which provides surgeons with real-time data during knee replacement procedures.
The funding, secured through the Northern Powerhouse Investment Fund II (managed by Mercia Ventures for the British Business Bank), will support Eventum’s expansion into the UK, US, and New Zealand. After receiving regulatory approval, the device has already been used in 300 procedures.
Eventum claims QuadSense can improve surgical outcomes and reduce post-surgery treatment costs, reaching £6,000 per case. The Northern Powerhouse Investment Fund II, a £660 million initiative, supports northern England businesses with loans of up to £2 million and equity investments of up to £5 million.
